Arcus Biosciences grants stock options, restricted stock units to three new employees

• Arcus Biosciences granted three new employees options to purchase 10,650 common shares under its 2020 Inducement Plan.
• The awards also included restricted stock units to acquire 5,350 common shares.
• The options carry an exercise price of $18.54 per share, matching the closing price on October 23, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcus Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610261635BIZWIRE_USPR_____20261026_BW005559) on October 26, 2026, and is solely responsible for the information contained therein.